Andreas Haffner - Dr Ing Member Affairs
DRPRY Stock | 6.06 0.09 1.46% |
Insider
Andreas Haffner is Member Affairs of Dr Ing hc
Age | 58 |
Phone | 49 711 911 0 |
Web | https://www.porsche.com/international |
Similar Executives
Showing other executives | INSIDER Age | ||
Manfred Doss | Porsche Automobile Holding | 65 | |
Sabine Kohleisen | Mercedes Benz Group AG | 59 | |
Thomas Laubert | Mercedes Benz Group AG | 50 | |
Hubertus Troska | Mercedes Benz Group AG | 63 | |
Hannes Ruoff | Porsche Automobile Holding | N/A | |
Ola Kallenius | Mercedes Benz Group AG | 54 | |
Lutz Meschke | Porsche Automobile Holding | 57 | |
Jens Brucker | Porsche Automobile Holding | N/A | |
Lutz Meschke | Dr Ing hc | 57 | |
Markus Schafer | Mercedes Benz Group AG | 58 | |
Harald Wilhelm | Mercedes Benz Group AG | 57 | |
Kapila Perrera | Porsche Automobile Holding | 64 | |
Jorg Burzer | Mercedes Benz Group AG | 53 | |
Detlev Platen | Dr Ing hc | 59 | |
Johannes Lattwein | Porsche Automobile Holding | N/A | |
George Wills | Porsche Automobile Holding | N/A | |
Steffen Hoffmann | Mercedes Benz Group AG | 53 | |
Albrecht Bamler | Porsche Automobile Holding | 65 | |
Renata Brungger | Mercedes Benz Group AG | 62 | |
Albrecht Reimold | Dr Ing hc | 62 | |
Wolfgang Leimgruber | Porsche Automobile Holding | N/A |
Dr Ing hc Leadership Team
Elected by the shareholders, the Dr Ing's board of directors comprises two types of representatives: Dr Ing inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DRPRY. The board's role is to monitor Dr Ing's management team and ensure that shareholders' interests are well served. Dr Ing's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dr Ing's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lutz Meschke, CFO Board | ||
Michael Steiner, Member RD | ||
Albrecht Reimold, Member Logistics | ||
Detlev Platen, Head Board | ||
Barbara Frenkel, Member Procurement | ||
Andreas Haffner, Member Affairs | ||
Oliver Blume, Chairman CEO |
DRPRY Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Dr Ing a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Profit Margin | 0.14 % | |||
Operating Margin | 0.20 % | |||
Revenue | 36.76 B | |||
Gross Profit | 8.99 B | |||
EBITDA | 9.38 B | |||
Net Income | 4.03 B | |||
Book Value Per Share | 25.19 X | |||
Cash Flow From Operations | 6.42 B | |||
Number Of Employees | 36.52 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for DRPRY Pink Sheet Analysis
When running Dr Ing's price analysis, check to measure Dr Ing's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Ing is operating at the current time. Most of Dr Ing's value examination focuses on studying past and present price action to predict the probability of Dr Ing's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Ing's price. Additionally, you may evaluate how the addition of Dr Ing to your portfolios can decrease your overall portfolio volatility.